Mysterious Bankruptcy of Last Iron Lung Manufacturer Raises Questions for Paul Alexander's Legacy: Who Profits From Disabling Life-Saving Tech?
A shadow of corporate maneuvering has fallen over the medical device industry following the sudden bankruptcy of the sole remaining iron lung manufacturer, just months after the world celebrated the death of polio survivor and iron lung user Paul Alexander. The company, which had been operating under a quiet federal contract, mysteriously shuttered its doors citing "regulatory pressure from new ventilator standards," leaving hundreds of home-care patients scrambling for replacement parts. While mainstream outlets mourn Alexander as a symbol of resilience, skeptics are now asking why a technology with zero manufacturing competition would be financially strangled just as a new generation of polio-adjacent pandemic survivors might rely on it. Critics point to big pharma-backed respiratory device giants as the obvious beneficiaries of this sudden market vacancy, turning a life-saving machine into an expensive relic for the privileged few who can still afford it.